Ibrahim Abouleish was born on March 23, 1937 and died on June 15, 2017.
He started out with his chemistry and medicine studies at the age of 19 in Austria.
Abouleish completed his doctorate in 1969 in the field of pharmacology and then worked in leading positions within pharmaceutical research.
During this time Abouleish was granted patents for a number of new medicines, especially for osteoporosis and arteriosclerosis.
Ibrahim Abouleish passed away at 80 years old.